New Drug Development Services
CDX models
- Categories:Oncology in vivo
- Time of issue:2023-09-07 16:01:43
- Views:0
CDX Transplant Model Platform: Accelerating Cancer Research
We are dedicated to providing a comprehensive and reliable platform for CDX (Cell-Derived Xenograft) transplantation models. Here's what sets us apart:
1. Extensive Collection of Tumor Cell Lines
Our platform boasts access to over 400 different tumor cell lines, covering a wide spectrum of cancer types and subtypes. This diverse collection enables you to select the most suitable cell lines for your research, ensuring relevance to your specific area of study.
2. Decades of Expertise in Experimental Design and Management
Our team is comprised of seasoned experts with over a decade of experience in the field of CDX models. From experienced researchers and quality control specialists to project managers, our team's collective knowledge ensures the smooth execution of your projects. We understand the intricacies of CDX models and can provide valuable insights into their design and implementation.
Inoculation Techniques:
• Subcutaneous Inoculation
• Bilateral Inoculation (Oncolytic Virus)
• Orthotropic
Dosing techniques:
it;i.v;i.p.;i.m.; p.o.; intransal
3. Scientific Support from a PhD-led Research Team
Our scientific team is composed of PhDs with extensive industry experience. They are dedicated to providing scientific support for every project. Whether it's designing experiments, troubleshooting, or offering guidance on data interpretation, our experts are here to ensure your research is on the right track.
4. Meticulous and Traceable Experimental Records
We place a premium on data integrity and compliance with regulatory requirements. Our platform maintains comprehensive and traceable experimental records, making it easy for you to meet reporting and documentation standards. Rest assured, your research is in safe hands.
• Model Quality Control
• STR Analysis
• Mycoplasma/Chlamydia Detection
• Growth Curves
• Cell Viability Testing
• Mouse Health Monitoring
• Robust QA Processes
5. Targeted Flow Cytometry for Cell Validation
In addition to routine STR (Short Tandem Repeat) and mycoplasma and chlamydia testing, we offer targeted flow cytometry to validate the cells you intend to use. This ensures that the cells meet the specific requirements of your project, enhancing the reliability of your results.
S | A | Cancer types | Number of models |
CANCER | Hematologic malignancies (HEMATO) | Lymphoma (LY) | 32 |
Chronic myeloproliferitve neoplasm (CMP) | 3 | ||
Myelodisplasic syndrome (MDS) | |||
Eosinophilia (EOS) | 1 | ||
Leukemia (LK) | 26 | ||
Myeloma (MYMA) | 10 | ||
Mastocytosis (MAS) | |||
Solid tumors (SOLID) | Skin (SK) | ||
Musculoskeletal and vascular systems (MSKV) | |||
Nervous system (NS) | |||
Endocrine System (ES) | |||
Urinary system (US) | |||
Female reproductory system (FRS) | |||
Male reproductory system (MRS) | |||
Head and neck (HNC) | |||
Torax (TX) | |||
Digestive system (DS) |
- Tel 15010000264
- E-mail limy@imodels.tech
- Tel 13810723384
- Top
InnoModels Biotechnology (Beijing) Co., Ltd.
TEL:15010000264 13810723384
Email:cndw@imodels.tec
Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing
Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company